Elanix Biotechnologies AG (FRA:ELN) Debt-to-Asset : 0.00 (As of Dec. 2018)

Elanix Biotechnologies AG Debt-to-Asset Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Debt-to-Asset		Get a 7-Day Free Trial					0.52	-	-	-	-

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Debt-to-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Elanix Biotechnologies AG's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Debt-to-Asset falls into.

Elanix Biotechnologies AG Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Elanix Biotechnologies AG's Debt-to-Asset for the fiscal year that ended in Dec. 2018 is calculated as

Elanix Biotechnologies AG's Debt-to-Asset for the quarter that ended in Dec. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG  (FRA:ELN) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Elanix Biotechnologies AG Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description